NDRA
ENDRA Life Sciences Inc.
Next earnings Aug 12, 2026 · consensus $-1.16 EPS
Last earnings -0.6% on 2026-03-31
$4.99
▲ +16.05%$4.99▲ +56.43%
over 1Y
L $3.19EODHDH $8.84
Earnings Dividend Split Congress buy Congress sellGrouped by date · hover a pin to expand
Today+16.0%
1W-3.7%
1M-6.9%
3M+14.7%
YTD+16.3%
1Y+56.4%
Hold
Conviction
Horizon
Medium (3–12mo)
Street · 7 analysts
Buy
Conservative balance sheet (liabilities/equity 0.71x).
ENDRA Life Sciences Inc. shows $0.00 in FY2020 revenue, and -310.9% ROE.
Sources: SEC EDGAR (CIK 0001681682, latest 10-Q filed 2026-05-15) · EODHD · as of 6/26/2026, 6:42:13 PM.
Research and education only — not financial advice. EDGAR is not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities EDGAR rates; see Disclosures. Past performance does not guarantee future results. Do your own research.